Evidence map›Paper›PMID 39770917›Full record

ArticleNutrients2024

Venkata Bala Sai Chaitanya Thunuguntla, Laura Kate Gadanec, Catherine McGrath, Joanne Louise Griggs, Puspha Sinnayah, Vasso Apostolopoulos, Anthony Zulli, Michael L Mathai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Targeting L-arginine/NO/cGMP/KFrontiers in pharmacology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Venkata Bala Sai Chaitanya ThunuguntlaInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.ORCID 0000-0001-9506-4565
Laura Kate GadanecInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.ORCID 0000-0002-4801-8061
Catherine McGrathInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.ORCID 0009-0004-6956-3925
Joanne Louise GriggsInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Puspha SinnayahInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.ORCID 0000-0002-9811-7236
Vasso ApostolopoulosInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.ORCID 0000-0001-6788-2771
Anthony ZulliInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Michael L MathaiInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.

Funding

Gencor Pacific Ltd N/A
6 · The paper itself

Abstract

backgroundObesity is a risk factor for developing cardiovascular diseases (CVDs) by impairing normal vascular function. Natural products are gaining momentum in the clinical setting due to their high efficacy and low toxicity.

methodsC57BL/6J male mice (

resultsThe results demonstrated that CFE and CFE + LOR treatments significantly reduced weight gain (17%; 24%) and fat mass deposition (14%; 16%). A HFD markedly reduced acetylcholine-mediated relaxation (

conclusionsThus, CFE alone or in combination with LOR could serve as an alternative strategy for preventing obesity-related cardiovascular diseases.

Indexed as

ApocynaceaeDiet, High-FatEndoplasmic Reticulum Chaperone BiPMice, Inbred C57BLNitric Oxide Synthase Type IIIObesityPlant ExtractsAnimalsAnti-Obesity AgentsEndothelium, VascularHeat-Shock ProteinsMaleMiceMice, ObeseTyrosineVasodilation3-nitrotyrosineAnti-Obesity AgentsEndoplasmic Reticulum Chaperone BiPHeat-Shock ProteinsHspa5 protein, mouseNitric Oxide Synthase Type IIINos3 protein, mousePlant ExtractsTyrosinebio-active compoundsCaralluma fimbriata extracthigh-fat dietlorcaserinnatural productobesityvascular dysfunction

Identifiers

PMID39770917
PMCPMC11678847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.